Lexicon Pharmaceuticals reported $-24587000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2973M 926M
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
AstraZeneca AZN:LN 258259.83M 36783.7M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Clovis Oncology CLVS:US $ -71.37M 11.08M
Coherus Biosciences CHRS:US $ -50.15M 45.93M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Halozyme Therapeutics HALO:US $ 30.01M 51.62M
Illumina ILMN:US $ 121M 69M
Insmed INSM:US $ -95144000 908K
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Lexicon Pharmaceuticals LXRX:US $ -24587000 1.11M
Macrogenics MGNX:US $ -41.3M 25.14M
Mannkind MNKD:US $ -29.02M 3.02M
Novartis NOVN:VX SF 4129M 217M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Regulus Therapeutics RGLS:US $ -7.26M 0.54M
Sarepta Therapeutics SRPT:US $ -228.09M 123.95M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M
United Therapeutics UTHR:US $ 150.6M 158.1M
Vanda Pharmaceuticals VNDA:US $ 3.79M 11.35M